To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

Post Archives

March 12, 2024
Corporate Sponsorship Availability to Support EBCI's Mission

Your company can support EBCI's mission by sponsoring our Know All Your Treatment Options (KAYTO) online event, set for May 17, 2024.

Read More
March 10, 2024
Understanding Syndromes Associated with CNS Tumors

Several genetic syndromes have been shown to increase the likelihood of developing central nervous system tumors.

Read More
March 7, 2024
Clinical Trial for Pediatric Patients with Diffuse Intrinsic Pontine Glioma (DIPG)

SonALAsense is currently recruiting patients in a Phase 1/2 Clinical Trial in DIPG, which uses Sonodynamic Therapy (SDT).

Read More
March 4, 2024
2024 National HOPE Award Nominations Now Open

Nominations are being sought for the 2024 National HOPE award.

Read More
February 29, 2024
A Message from Our CEO: Help DCVax®-L Gain FDA Approval

DCVax®-L represents a novel form of immunotherapy, developed by Northwest Biotherapeutics, which could be a new treatment option for glioblastoma. Join the movement to seek FDA approval.

Read More
February 22, 2024
New Website for PCNS Lymphoma

New dedicated website for the Prospect primary central nervous system lymphoma study.

Read More
February 15, 2024
Access All of Your Medical Records with xCures

xCures can work with your doctor to help you access new treatments by providing access to your electronic medical records.

Read More
February 8, 2024
Clinical Trial for Patients with Primary Central Nervous System Lymphoma (PCNSL)

Ono Pharma is actively recruiting patients with Primary Central Nervous System Lymphoma (PCNSL) for the PROSPECT Study, which is evaluating an oral medicine called Tirabrutinib.

Read More
January 29, 2024
Revolutionizing Cancer Care: Advances in Radiation Therapy for Brain Tumors

Modern radiation therapy for brain tumors, marked by precision, personalization, safety, and ongoing innovation, holds promise for enhancing patient outcomes and instilling hope in challenging diagnoses.

Read More
January 29, 2024
EBCI Expands Access to Pediatric Treatments

Sasha Quijano-Edwards, in her new role as Pediatric Clinical Trial Coordinator & Patient Navigator, Sasha hopes to provide much needed support to patients and families.

Read More
January 23, 2024
Clinical Study for Patients with Newly Diagnosed Metastatic Brain Tumors

The Roads Clinical Study is designed for patients diagnosed with a metastatic brain tumor.

Read More
January 18, 2024
Patients Need YOUR Help to Access Treatments: Support The Promising Pathway Act

The Promising Pathway Act will have a massive positive impact on treatments for GBM. Contact your senators and representatives today to ask for their support.

Read More


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram